5Kata AM.Metabolism of the failing heart[J].Cardioscience,1993,4:199-203.
6Conway MA,Allis J,Ouewrkerk R,et al.Detection of phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 32 magnetic resonance spectoscopy[J].Lancet,1992,338:973-978.
7Hardy CJ,Weiss RG,Bottomley PA,et al.Altered myocardial high energy phosphatemetabolites in patients with dilated cardiomyopathy[J].AM Heart J,1991,122:795-801.
8Neubauer S,Hern M,Pabsr T,et al.Contribution of 31 p-magnetic resonance spectroscopy to understanding of dilatod heart muscle disease[J].Eur Heart J,1995,16:115-118.
9Saks VA,Strumia E.Phosphocreatine mocular and cellular aspets of the mechanism of cardioprotective action[J].Curr Ther Res,1992,53:585-598.
10Sergio F,Linzia C,Fibrazio P,et al.Hemodynamic effects of phosphato in patients with congestive heart failure.A double-blind comparison trial versus placebo[J].Clin Cardiol,l996,l9:699-703.